| A | B |
|---|
| drug | single substance in a medicine |
| medicine | used to prevent, treat, cure illness |
| pharmacogenetics | tailoring drugs to an individual |
| receptor | part of a cell where a drug can bind |
| contraindication | medical reason for not taking a drug |
| dose | amount of drug administered |
| double-blind | neither recipient/giver has knowledge |
| drug hypersensitivity | allergic reaction to a drug |
| side effects | unintended actions of a drug |
| teratogen | environmental agent altering development |
| lifestyle drugs | drugs prescribe for natural conditions |
| over-the-counter (OTC) drugs | do not require a prescription |
| psychoactive | alters mood and perception |
| direct-to-consumer advertising (DTCA) | marketing of drugs to consumers |
| drug abuse | persistent/excessive use of a drug |
| addiction | dependence on a drug |
| physical dependence | physiological state of presence |
| cocaine | stimulant causing euphoria |
| habituation | psychological dependence |
| psychological dependence | results from pleasant mental effects |
| stimulants | increases activity of the CNS |
| tolerance | use requires increased exposure |
| withdrawal symptoms | reactions when ceasing use of a drug |
| amphetamines | synthetic drugs that stimulate the CNS |
| caffeine | natural stimulant found in plants |
| club drugs | psychoactive chemicals used for partying |
| ecstasy (MDMA) | club drug with stimulant/pleasure effects |
| gamma-hydroxybutyrate (GHB) | dangerous drug with unpleasant effects |
| hypnotics | depresses the CNS, inducing drowsiness |
| ketamine | anesthetic used as a club drug |
| opiates | CNS depressants derived from opium |
| sedatives | CNS depressants used to relieve anxiety |
| rohypnol | powerful tranquilizer |
| tranquilizers | CNS depressants that relax the body |
| hallucinogens | alter sensory processing in the brain |
| hashish | sticky resin of the cannabis plant |
| LSD | hallucinogenic chemical |
| marijuana | psychoactive drug of the cannabis saliva |
| phencyclidine (PCP) | originally developed as an animal anesthetic |
| inhalants | produce alcohol-like intoxication |
| carcinogens | substances that can cause cancer |
| chewing tobacco | smokeless tobacco placed in the mouth |
| moist snuff | most hazardous form of smokeless tobacco |
| nicotine | addicting chemical in tobacco |
| snuff | finely cut smokeless tobacco |
| tar | residue of tobacco smoke |
| alveoli | air sacs of the lungs |
| bronchitis | inflammation of the bronchi |
| chronic obstructive pulmonary disease (COPD) | diseases that restrict oxygen |
| emphysema | progressive degeneration of alveoli |
| trachea | upper part of respiratory tract |
| nicotine replacement therapy | alternative delivery to smoking |
| quit date | the day smoking will cease |
| dangerous (binge) drinking | results in harmful consequences |
| ethyl alcohol (ethanol) | consumable alcohol |
| proof | twice the percentage of alcohol |
| secondhand binge effects | caused by another 's binge drinking |
| acetaldehyde | from the liver breaking down alcohol |
| blood alcohol content (BAC) | quantity of alcohol in the blood |
| congeners | chemicals in alcohol |
| hangover | physical woes from excessive alcohol |
| fetal alcohol syndrome | defects from a mother's alcohol use |
| alcohol abuse | frequent binge drinking |
| alcoholism | loss of control over drinking alcohol |
| delirium tremens (DTs) | alcohol withdrawal |
| bender | several days of binge drinking |
| blackout | failure to recall events from drinking |
| codependency | nonaddicted people identify with alcoholic |
| denial | refusal to admit problem |
| enabling | denial of/excuses for an alcoholic |
